These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2013119)

  • 1. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
    Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
    Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study.
    Friedman HS; Krischer JP; Burger P; Oakes WJ; Hockenberger B; Weiner MD; Falletta JM; Norris D; Ragab AH; Mahoney DH
    J Clin Oncol; 1992 Feb; 10(2):249-56. PubMed ID: 1732426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin chemotherapy in patients with recurrent high-grade glioma.
    Murray LJ; Bridgewater CH; Levy D
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):55-61. PubMed ID: 20952169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data Center.
    Vermorken JB; Gundersen S; Clavel M; Smyth JF; Dodion P; Renard J; Kaye SB
    Ann Oncol; 1993 Apr; 4(4):303-6. PubMed ID: 8518220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised phase II trial of carboplatin and iproplatin in advanced urothelial cancer.
    de Wit R; Tesselaar M; Kok TC; Seynaeve C; Rodenburg CJ; Verweij J; Helle PA; Stoter G
    Eur J Cancer; 1991; 27(11):1383-5. PubMed ID: 1835851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
    Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
    Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
    Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
    Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.
    Roci E; Cakani B; Brace G; Bushati T; Rroji A; Petrela M; Kaloshi G
    Med Arch; 2014; 68(2):140-3. PubMed ID: 24937942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
    Poisson M; Péréon Y; Chiras J; Delattre JY
    J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin chemotherapy in patients with recurrent high-grade glioma.
    Kaloshi G; Petrela M
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):495. PubMed ID: 21459563
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
    Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
    J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of carboplatin or iproplatin in cervical cancer.
    Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
    Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group.
    van Wijk FH; Lhommé C; Bolis G; Scotto di Palumbo V; Tumolo S; Nooij M; de Oliveira CF; Vermorken JB;
    Eur J Cancer; 2003 Jan; 39(1):78-85. PubMed ID: 12504662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG).
    van Glabbeke M; Renard J; Pinedo HM; Cavalli F; Vermorken J; Sessa C; Abele R; Clavel M; Monfardini S
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):255-62. PubMed ID: 3281842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of carboplatin in children with progressive low-grade gliomas.
    Gururangan S; Cavazos CM; Ashley D; Herndon JE; Bruggers CS; Moghrabi A; Scarcella DL; Watral M; Tourt-Uhlig S; Reardon D; Friedman HS
    J Clin Oncol; 2002 Jul; 20(13):2951-8. PubMed ID: 12089224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicities of the platinum antineoplastic agents.
    Markman M
    Expert Opin Drug Saf; 2003 Nov; 2(6):597-607. PubMed ID: 14585068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of iproplatin in advanced ovarian carcinoma.
    Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
    J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
    Villani V; Pace A; Vidiri A; Tanzilli A; Sperati F; Terrenato I; Mariantonia C; Casini B; Metro G; Maschio M; Tatiana K; Cognetti F; Fabi A
    J Neurooncol; 2019 Aug; 144(1):211-216. PubMed ID: 31273578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.